entertainment -WSS

entertainment

author：fashion 2025-09-28 23:51:28 - browse：74

A venomous West African Green Mamba snake — Mark Ralston/AFP/Getty Images

Antivenom, like Mexican Coke or grandma’s cookies, is still made the old-fashioned way. In antivenom’s case, the recipe is straightforward: Pump a horse full of sub-lethal doses of venom from various local snakes, wait for them to develop an immune response, tap their blood, purify out antibodies, bottle, and freeze.

This vampiric, century-old process still reigns because of the unique scientific challenge posed by snake venoms. Researchers are skilled at making antibodies in the lab against specific targets. But venoms can vary vastly. A viper induces “circulatory shock” by shredding proteins in your blood, whereas a mamba blocks receptors on your muscles, paralyzing you. A king cobra seems to have multiple methods of murder. How do you build a drug against them all?

“Snake venom is one of the most complex things you can come across,” said Kartik Sunagar, head of the Evolutionary Venomics Lab in Bengaluru, India.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Methadone doses haven’t kept up in the age of fentanyl

Wikipedia

knowledge

WSS

Gene therapy for Afghan refugees’ infant will be fully covered

Unique patient identifier: Experts argue the benefits, pitfalls

How to use technology to prevent future drug shortages

Readout Newsletter: Amgen, Regeneron, BGI Group and more

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Maui's cultural, historic landmarks damaged in the devastating wildfires

explore

entertainment

hotspot

23andMe had bad news about my health. I wish a person had delivered it

Maui's cultural, historic landmarks damaged in the devastating wildfires

Hepatitis C has a cure — but many Americans still lack access to it

Updated Covid vaccine has 54% effectiveness, new study suggests

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

For Cytokinetics, FDA rejection of heart drug would help, not hinder

Novavax promises a turnaround & Lilly roils the obesity market

A single Democrat is willing to weaken Medicare negotiation power

Apple is now the first public company to be valued at $3 trillion

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

hotspot

Anavex keeps shifting the goalposts in its clinical trials

Friends ask where James Watson's attitudes about race came from

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Naloxone nonprofit donates 200,000 doses after FDA approval

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Wikipedia

focus

knowledge

hotspot